Beam Therapeutics Inc. (BEAM) /
The profitability of Beam Therapeutics Inc. over the past 7 years
Chart Beam Therapeutics Inc.: operating income, net income, fiscal 2019–2025 Open the chart →Beam Therapeutics Inc. reported a net loss of $79.99M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $383.69M. It reported a loss in all 7 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$383.69M | -$79.99M |
| 2024ended Dec 31, 2024 | -$415.57M | -$376.74M |
| 2023ended Dec 31, 2023 | -$176.49M | -$132.53M |
| 2022ended Dec 31, 2022 | -$338.48M | -$289.09M |
| 2021ended Dec 31, 2021 | -$392.46M | -$370.64M |
| 2020ended Dec 31, 2020 | -$132.76M | -$194.59M |
| 2019ended Dec 31, 2019 | -$75.15M | -$78.33M |
Fiscal years as Beam Therapeutics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Beam Therapeutics Inc.
- The revenue of Beam Therapeutics Inc.
- The cash flow of Beam Therapeutics Inc.
- The debt of Beam Therapeutics Inc.
- All of Beam Therapeutics Inc.'s financials, charted
Companies of a similar size
- CLSKCleanSpark, Inc.
- ADEAADEIA INC.
- QSQUANTUMSCAPE CORPORATION
- BHFBrighthouse Financial, Inc.
- UPSTUpstart Holdings, Inc.
Not investment advice. This page shows what Beam Therapeutics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.